TNFRSF1B and melanoma: As macrophages are one of the key drivers of BRAFV600E+ melanoma resistance to MEKi [10, 23], it was also critical to explore whether TNFR2+ cell lines could favorably respond to activated monocyte-derived macrophages (Additional file 1: Fig. S3A).